Find research datasets worth reusing
Search datasets from major research repositories and use ShareScore to quickly assess how well each record supports discovery, access, and reuse.
878
datasets available to search
ShareScore release 0.9.0
Dataset results
878 results for “human factors”
A Study of Trastuzumab Emtansine Versus Taxane in Participants With Human Epidermal Growth Factor Receptor 2 (HER2)-Positive Advanced Gastric Cancer
ClinicalTrials.gov study NCT01641939. IPD Sharing: Not stated. Countries: 28. Publications: 2.
Cetuximab and Cisplatin in the Treatment of "Triple Negative" (Estrogen Receptor [ER] Negative, Progesterone Receptor [PgR] Negative, and Human Epidermal Growth Factor Receptor 2 [HER2] Negative) Meta
ClinicalTrials.gov study NCT00463788. IPD Sharing: Not stated. Countries: 11. Publications: 1.
Study in Participants With Early-Stage or Locally Advanced Human Epidermal Growth Factor Receptor (HER) 2-Positive Breast Cancer to Evaluate Treatment With Trastuzumab Plus (+) Pertuzumab + Docetaxel
ClinicalTrials.gov study NCT02586025. IPD Sharing: Not stated. Countries: 4. Publications: 1.
Pembrolizumab/Placebo Plus Trastuzumab Plus Chemotherapy in Human Epidermal Growth Factor Receptor 2 Positive (HER2+) Advanced Gastric or Gastroesophageal Junction (GEJ) Adenocarcinoma (MK-3475-811/KE
ClinicalTrials.gov study NCT03615326. IPD Sharing: YES. Countries: 20. Publications: 4.
A Study of Subcutaneous At Home Administration of Trastuzumab (Herceptin) in Participants With Human Epidermal Growth Factor Receptor 2-positive (HER2+) Early Breast Cancer (eBC)
ClinicalTrials.gov study NCT01926886. IPD Sharing: Not stated. Countries: 2. Publications: 1.
Effect Of Capros Supplementation On Cardiovascular Disease Risk Factors In Humans
ClinicalTrials.gov study NCT01858376. IPD Sharing: Not stated. Countries: 1. Publications: 9.
A Study of Pertuzumab and Trastuzumab Subcutaneous (SC) Treatment in Combination With a Taxane in Participants With Human Epidermal Growth Factor Receptor 2 (HER2)-Positive Metastatic Breast Cancer
ClinicalTrials.gov study NCT02019277. IPD Sharing: Not stated. Countries: 1. Publications: 1.
Neoadjuvant Endocrine Therapy in Hormone Receptor-Positive, Human Epidermal Growth Factor Receptor 2 (HER2)-Negative Node-Negative Breast Cancer
ClinicalTrials.gov study NCT03219476. IPD Sharing: NO. Countries: 1. Publications: 1.
A Study of the Safety of Subcutaneously Administered Trastuzumab (Herceptin) in Participants With Early and Locally Advanced Human Epidermal Growth Factor Receptor 2 (HER2)-Positive Breast Cancer
ClinicalTrials.gov study NCT01940497. IPD Sharing: Not stated. Countries: 1. Publications: 1.
Vinflunine Plus Trastuzumab in Human Epidermal Growth Factor Receptor 2 (HER2neu) Over-Expressing Metastatic Breast Cancer
ClinicalTrials.gov study NCT00284180. IPD Sharing: Not stated. Countries: 1. Publications: 1.
Talazoparib For Neoadjuvant Treatment Of Germline BRCA1/2 Mutation Patients With Early Human Epidermal Growth Factor Receptor 2 Negative Breast Cancer
ClinicalTrials.gov study NCT03499353. IPD Sharing: YES. Countries: 1. Publications: 2.
A Study of Recombinant AAV2/6 Human Factor 8 Gene Therapy SB-525 (PF-07055480) in Subjects With Severe Hemophilia A
ClinicalTrials.gov study NCT03061201. IPD Sharing: YES. Countries: 1. Publications: 2.
Afatinib (BIBW2992) in HER2 (Human Epidermal Growth Factor Receptor 2)-Overexpressing Inflammatory Breast Cancer
ClinicalTrials.gov study NCT01325428. IPD Sharing: Not stated. Countries: 7. Publications: 1.
Tocilizumab Real-Life Human Factors (RLHFs) Validation Study
ClinicalTrials.gov study NCT02682823. IPD Sharing: Not stated. Countries: 1. Publications: 1.
A Study of Trastuzumab Emtansine (Trastuzumab-MCC-DM1, T-DM1) in Combination With Pertuzumab Administered to Patients With Human Epidermal Growth Factor Receptor-2 (HER2)-Positive Locally Advanced or
ClinicalTrials.gov study NCT00875979. IPD Sharing: Not stated. Countries: 7. Publications: 1.
A Combination Study of Kadcyla (Trastuzumab Emtansine) and Capecitabine in Participants With Human Epidermal Growth Factor Receptor 2 (HER2)-Positive Metastatic Breast Cancer (mBC) or HER2-Positive Lo
ClinicalTrials.gov study NCT01702558. IPD Sharing: Not stated. Countries: 12. Publications: 1.
LUX-Breast 2; Afatinib in HER2 (Human Epidermal Growth Factor Receptor)-Treatment Failures
ClinicalTrials.gov study NCT01271725. IPD Sharing: Not stated. Countries: 6. Publications: 1.
A Study Evaluating Trastuzumab Emtansine Plus Pertuzumab Compared With Chemotherapy Plus Trastuzumab and Pertuzumab for Participants With Human Epidermal Growth Factor Receptor 2 (HER2)-Positive Breas
ClinicalTrials.gov study NCT02131064. IPD Sharing: Not stated. Countries: 10. Publications: 3.
Herceptin (Trastuzumab) in Treating Women With Human Epidermal Growth Factor Receptor (HER) 2-Positive Primary Breast Cancer
ClinicalTrials.gov study NCT00045032. IPD Sharing: Not stated. Countries: 33. Publications: 18.
A Study of Pertuzumab in Combination With Trastuzumab and Chemotherapy in Participants With Human Epidermal Growth Factor Receptor 2 (HER2)-Positive Metastatic Gastroesophageal Junction or Gastric Can
ClinicalTrials.gov study NCT01774786. IPD Sharing: Not stated. Countries: 32. Publications: 4.
ScienceDex guides
Understand access before you commit
These curated guides explain access requirements, typical timelines, costs, and reuse considerations for widely used research datasets.
Allen Brain Atlas
Allen Brain Atlas is an Allen Institute collection of brain map atlases, datasets, APIs, and analysis tools covering mouse, human, and non-human primate brain resources.
Annotated Behaviour and Observability Dataset (ABODe)
ABODe is a University of Edinburgh DataShare dataset for behavior classification in group-housed mice using home-cage video, identities, bounding boxes, ground-plate positions, and annotator labels.
DANDI Archive for NWB datasets
DANDI is a BRAIN Initiative archive for publishing and sharing neurophysiology data, including electrophysiology, optophysiology, and behavioral data packaged as NWB and related standards.
International Brain Laboratory public data
The International Brain Laboratory public data releases expose standardized mouse decision-making experiments, including Neuropixels recordings, widefield calcium imaging, behavior, and session metadata accessed through the ONE API.
OpenNeuro
OpenNeuro is a free, open platform for sharing neuroimaging datasets, with public search, dataset pages, and download paths for web, S3, DataLad, and the OpenNeuro CLI.